Bryn Mawr Capital Management Inc’s Omega Protein OME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-30,423
Closed -$516K 385
2015
Q3
$516K Buy
+30,423
New +$474K 0.09% 256
2015
Q2
Sell
-20,982
Closed -$287K 604
2015
Q1
$287K Sell
20,982
-19,390
-48% -$224K 0.04% 392
2014
Q4
$427K Sell
40,372
-29,461
-42% -$349K 0.05% 293
2014
Q3
$873K Buy
69,833
+15,081
+28% +$210K 0.09% 227
2014
Q2
$749K Buy
54,752
+11,371
+26% +$149K 0.07% 271
2014
Q1
$524K Buy
43,381
+16,039
+59% +$184K 0.05% 338
2013
Q4
$336K Sell
27,342
-6,837
-20% -$80.2K 0.02% 437
2013
Q3
$348K Sell
34,179
-8,005
-19% -$74.8K 0.02% 412
2013
Q2
$379K Buy
+42,184
New +$425K 0.03% 282

Other funds holding OME

Bryn Mawr Capital Management Inc's OME Position: Q4 2015 in Review

Bryn Mawr Capital Management Inc sold out of Omega Protein (OME) in Q4 2015, closing a stake of 30,423 shares — an estimated $516K sold.

Bryn Mawr Capital Management Inc first reported a position in OME in Q2 2013 and held it in 9 quarters. The position peaked at $873K in Q3 2014. 136 funds tracked by Wall St. Rank hold OME as of Q4 2015.

  • Bryn Mawr Capital Management Inc reported no remaining Omega Protein position as of Q4 2015 after selling out during the quarter.
  • Bryn Mawr Capital Management Inc sold 30,423 Omega Protein shares in Q4 2015, an estimated $516K.
  • Bryn Mawr Capital Management Inc first reported a position in Omega Protein in Q2 2013 and held it in 9 quarters.
  • Bryn Mawr Capital Management Inc's Omega Protein position peaked at $873K in Q3 2014.
  • 136 funds tracked by Wall St. Rank held Omega Protein as of Q4 2015.

Based on Bryn Mawr Capital Management Inc's 13F filing for Q4 2015.